1.
Saugstad
OD
.
Acetaminophen and the developing brain. Reason for concern?
Neonatology
. 1661-7800
2.
Starko
KM
,
Ray
CG
,
Dominguez
LB
,
Stromberg
WL
,
Woodall
DF
.
Reye’s syndrome and salicylate use
.
Pediatrics
.
1980
Dec
;
66
(
6
):
859
64
.
[PubMed]
0031-4005
3.
American Psychiatric Association
.
Diagnostic and Statistical Manual of Mental Disorders
. 5th ed.
Arlington, VA, USA
:
American Publishing
;
2013
.
4.
Saunders
A
,
Woodland
J
,
Gander
S
.
A comparison of prenatal exposures in children with and without a diagnosis of autism spectrum disorder
.
Cureus
.
2019
Jul
;
11
(
7
):
e5223
.
[PubMed]
2168-8184
5.
Schultz
ST
.
Can autism be triggered by acetaminophen activation of the endocannabinoid system?
Acta Neurobiol Exp (Wars)
.
2010
;
70
(
2
):
227
31
.
[PubMed]
1689-0035
6.
Philippot
G
,
Gordh
T
,
Fredriksson
A
,
Viberg
H
.
Adult neurobehavioral alterations in male and female mice following developmental exposure to paracetamol (acetaminophen): characterization of a critical period
.
J Appl Toxicol
.
2017
Oct
;
37
(
10
):
1174
81
.
[PubMed]
0260-437X
7.
Philippot
G
,
Hallgren
S
,
Gordh
T
,
Fredriksson
A
,
Fredriksson
R
,
Viberg
H
.
A cannabinoid receptor type 1 (CB1R) agonist enhances the developmental neurotoxicity of acetaminophen (paracetamol)
.
Toxicol Sci
.
2018
Nov
;
166
(
1
):
203
12
.
[PubMed]
1096-6080
8.
Philippot
G
,
Nyberg
F
,
Gordh
T
,
Fredriksson
A
,
Viberg
H
.
Short-term exposure and long-term consequences of neonatal exposure to Δ(9)-tetrahydrocannabinol (THC) and ibuprofen in mice
.
Behav Brain Res
.
2016
Jul
;
307
:
137
44
.
[PubMed]
0166-4328
9.
Masarwa
R
,
Levine
H
,
Gorelik
E
,
Reif
S
,
Perlman
A
,
Matok
I
.
Prenatal exposure to acetaminophen and risk for attention deficit hyperactivity disorder and autistic spectrum disorder: a systematic review, meta-analysis, and meta-regression analysis of cohort studies
.
Am J Epidemiol
.
2018
Aug
;
187
(
8
):
1817
27
.
[PubMed]
0002-9262
10.
Damkier
P
.
Prenatal exposure to acetaminophen and risk for attention deficit hyperactivity disorder and autistic spectrum disorder: a systematic review, meta-analysis, and meta-regression analysis of cohort studies
.
Am J Epidemiol
.
2018
Dec
;
187
(
12
):
2717
8
.
[PubMed]
0002-9262
11.
Damkier
P
,
Pottegård
A
,
dePont Christensen
R
,
Hallas
J
.
Annotations and reflections: pregnancy and paracetamol: methodological considerations on the study of associations between in utero exposure to drugs and childhood neurodevelopment
.
Basic Clin Pharmacol Toxicol
.
2015
Jan
;
116
(
1
):
2
5
.
[PubMed]
1742-7835
12.
Olsen
J
,
Liew
Z
.
Fetal programming of mental health by acetaminophen? Response to the SMFM statement: prenatal acetaminophen use and ADHD
.
Expert Opin Drug Saf
.
2017
Dec
;
16
(
12
):
1395
8
.
[PubMed]
1474-0338
13.
Bittker
SS
,
Bell
KR
.
Postnatal acetaminophen and potential risk of autism spectrum disorder among males.
Behav Sci
2020
, 10, 26; doi:10:3390/bs10010026
14.
Ji
Y
,
Azuine
RE
,
Zhang
Y
,
Hou
W
,
Hong
X
,
Wang
G
, et al
Association of cord plasma biomarkers of in utero acetaminophen exposure with risk of attention-deficit/hyperactivity disorder and autism spectrum disorder in childhood
.
JAMA Psychiatry
.
2019
Oct
;
•••
:
1
11
.
[PubMed]
2168-6238
15.
Alberti
A
,
Pirrone
P
,
Elia
M
,
Waring
RH
,
Romano
C
.
Sulphation deficit in “low-functioning” autistic children: a pilot study
.
Biol Psychiatry
.
1999
Aug
;
46
(
3
):
420
4
.
[PubMed]
0006-3223
16.
Ystrom
E
,
Gustavson
K
,
Brandlistuen
RE
,
Knudsen
GP
,
Magnus
P
,
Susser
E
, et al
Prenatal exposure to acetaminophen and risk of ADHD
.
Pediatrics
.
2017
Nov
;
140
(
5
):
e20163840
.
[PubMed]
0031-4005
17.
Allegaert
K
,
Mian
P
,
Lapillonne
A
,
van den Anker
JN
.
Maternal paracetamol intake and fetal ductus arteriosus constriction or closure: a case series analysis
.
Br J Clin Pharmacol
.
2019
Jan
;
85
(
1
):
245
51
.
[PubMed]
0306-5251
18.
Allegaert
K
,
van den Anker
JN
.
Perinatal and neonatal use of paracetamol for pain relief
.
Semin Fetal Neonatal Med
.
2017
Oct
;
22
(
5
):
308
13
.
[PubMed]
1744-165X
19.
Mian
P
,
Allegaert
K
,
Conings
S
,
Annaert
P
,
Tibboel
D
,
Pfister
M
, et al
Integration of placental transfer in a fetal-maternal physiologically based pharmacokinetic model to characterize acetaminophen exposure and metabolic clearance in the fetus
.
Clin Pharmacokinet
.
2020
Feb
;
Epub ahead of print
.
[PubMed]
0312-5963
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.